Prioritize terms that prevent stranded commitments and make failure or transition manageable. Price protection is incomplete if the clinic remains locked in after the arrangement can no longer serve its intended patients.
Proposed negotiation agenda—not model legal clauses:
| Clause | Buyer objective |
|---|---|
| Product and facility schedule | Identify permitted products, presentations and performing entities |
| Subcontracting | Notice and review of material facility or fulfilment changes |
| Regulatory change | Suspension, termination and orderly transition mechanisms |
| Pricing | Clear fees, programme dependencies and notice of changes |
| Minimum commitments | Ramp periods and relief for documented access or service failures |
| Service failures | Corrective action, meaningful remedies and termination rights |
| Quality and recalls | Responsibilities, records, notification and cost allocation |
| Data | Access, permitted use, security and exportability |
| Prepayments | Reconciliation, unused balances and refund treatment |
| Exit | Assistance, records, outstanding orders and patient communications |
| Insurance and liability | Coverage matched to the actual activities and risks |
Manufacturer offer terms can reserve amendment or termination rights. A pharmacy agreement should therefore explain what happens if the underlying offer changes, rather than implying that the clinic has secured a fixed patient price. (zepbound.lilly.com)
Have counsel review enforceability, liability allocation and state-specific requirements before signature.
Explore the table row by row
A working view of the research
Product and facility schedule
- Buyer objective
- Identify permitted products, presentations and performing entities
Sources cited on this page
- zepbound.lilly.com · Source 1 ↗https://zepbound.lilly.com/hcp/coverage-savings